GTR 85322373
Bids Are Invited For Acquisition Of Part I Chemotherapy Drugs, To Meet The Needs Of The Oncology Clinic Of The Military Hospital Of The Brasília Area, Under The Terms, Conditions And Requirements Established In The Notice And Annexes.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
85322373
Tendering Authority
Subscribe to view
Tender No
90010/2024
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Part I Chemotherapy Drugs, To Meet The Needs Of The Oncology Clinic Of The Military Hospital Of The Brasília Area, Under The Terms, Conditions And Requirements Established In The Notice And Annexes.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
17-09-2024
Closed
Work Detail
Acquisition Of Part I Chemotherapy Drugs, To Meet The Needs Of The Oncology Clinic Of The Military Hospital Of The Brasília Area, Under The Terms, Conditions And Requirements Established In The Notice And Annexes.. Abemaciclib, Abemaciclib, Abemaciclib, Abemaciclib, Abiraterone Acetate, Abiraterone Acetate, Acalabrutinib, Zoledronic Acid, Zoledronic Acid, Afatinib Dimaleate, Afatinib Dimaleate, Aflibercept, Aflibercept, Alectinib, Alfadarbepoetin, Amivantamab, Anastrozole, Apalutamide, Atezoliz Umab,Atezolizumab,Avelumab,Axitinib, Axitinib,Azacitidine,Bendamustine,Bendamustine,Bevacizumab,Bevacizumab,Bortezomib,Brentuximab,Brigatinib,Brigatinib,Brigatinib,Brigatinib,Cabazitaxel,Cabozantinib,Cabozantinib,Cabozantinib,Capecitabine,Capecitabine,Carboplatin,Carboplatin,Carboplatin,Carfil Zomib,Carmustine,Cemiplimab,Cetuximab ,Cetuximab,Cyclophosphamide,Cyclophosphamide,Cyclophosphamide,Cyproterone Acetate,Cyproterone Acetate,Cisplatin,Cisplatin,Cisplatin,Cytarabine,Cytarabine,Cytarabine,Cobimetinib Hemifumarate,Crizotinib,Crizotinib,Dabrafenib,Dabrafenib,Dacarbazine,Dacarbaz Ina,Dacarbazine,Daratumumab,Daratumumab,Daratumumab, Darolutamide,Dasatinib,Dasatinib,Decitabine,Degarelix,Degarelix,Denosumab,Denosumab,Trametinib,Trametinib,Docetaxel,Docetaxel,Doxorubicin Hydrochloride,Doxorubicin Hydrochloride,Doxorubicin Hydrochloride,Durvalumab,Durvalumab,Enfortumab,Enfortumab,Enzalutamide,Epir Rubicin Hydrochloride, Epirubicin Hydrochloride, Erdafitinib ,Erdafitinib,Erdafitinib,Eribulin Mesylate,Epoetin Alfa,Epoetin Alfa,Epoetin Alfa,Etoposide
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
6a92b064-d0ec-45dd-9878-963a09de6349.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.